secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeoVax Labs, Inc. (GOVX)
CIK:        0000832489
Form:       8-K
Filed at:   2025-09-30T23:59:59+00:00
Accession:  0001437749-25-030125
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeoVax raises ~$2.5M in registered direct offering; issues shares and warrants at $0.63
--------------------------------------------------------------------------------

- 3,968,256 shares sold at $0.63 each with warrants to buy 11,904,768 shares at $0.63.
- Gross proceeds ~$2.5M, net ~$2.325M after 7% placement agent fees.
- Warrants exercisable only upon shareholder approval; expire 5 years from approval.
- Roth Capital Partners acted as sole placement agent for the offering.
- Proceeds to advance immunotherapies and vaccines pipeline including R&D and clinical studies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832489/000143774925030125/0001437749-25-030125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832489/000143774925030125/govx20250930_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-030125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer